Indeed, a dysregulated Src activity has been associated with tumor growth and metastasis, inflammation-mediated carcinogenesis, and therapeutic resistance to traditional antineoplastic drugs (Caner et al., 2021; Ahn et al., 2018; Cardin et al., 2018; Dosch et al., 2020; Roskoski, 2015; Shao et al., 2022). This evidence concerns the gene SRC and neoplasm.